Quick Answer
ASP Isotopes Inc. reported Total Revenue of $4.14 million for fiscal year 2024.
ASP Isotopes Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | $4.14M +857.0% |
$433.0K | $0.00 | — |
| Net Income | -$32.42M -99.0% |
-$16.29M -229.5% |
-$4.95M | — |
| Diluted EPS | -$0.63 -28.6% |
-$0.49 | — | — |
| Total Assets | $94.35M +242.6% |
$27.54M +120.4% |
$12.50M +75.0% |
$7.14M |
| Stockholders Equity | $47.90M +193.9% |
$16.30M +66.0% |
$9.82M | $0.00 |
| R&D Expense | $3.14M +310.5% |
$764.6K -40.0% |
$1.27M | — |
| Operating Income | -$26.35M -64.3% |
-$16.04M -214.6% |
-$5.10M | — |
| Gross Profit | $1.60M +1051.0% |
$139.0K | $0.00 | — |
| Shares Outstanding | 72.07M +47.3% |
48.92M +36.2% |
35.91M +73.9% |
20.65M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $4.89M | +349.5% | +308.0% |
| Net Income | September 30, 2025 | -$12.89M | -75.3% | +82.8% |
| Diluted EPS | September 30, 2025 | -$0.15 | -25.0% | +85.4% |
| Total Assets | September 30, 2025 | $225.89M | +168.5% | +66.2% |
| Cash and Equivalents | September 30, 2024 | $51.57M | — | +552.1% |
| Stockholders Equity | September 30, 2025 | $74.07M | +91.4% | +193.6% |
| R&D Expense | September 30, 2025 | $3.10M | +199.5% | +252.1% |
| Operating Income | September 30, 2025 | -$14.97M | -175.5% | -25.1% |
| Gross Profit | September 30, 2025 | $423.2K | +43.9% | -26.0% |
| Shares Outstanding | September 30, 2025 | 93.38M | +36.5% | +11.3% |
- ASP Isotopes Inc. reported Total Revenue of $4.14 million for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +857.0% in Total Revenue compared to the prior fiscal year.
- ASP Isotopes Inc. reported Net Income of -$32.42 million for fiscal year 2024.
- ASP Isotopes Inc. showed a decrease of -99.0% in Net Income compared to the prior fiscal year.
- ASP Isotopes Inc. reported Diluted EPS of $0.63 per share (loss) for fiscal year 2024.
- ASP Isotopes Inc. showed a decrease of -28.6% in Diluted EPS compared to the prior fiscal year.
- ASP Isotopes Inc. reported Total Assets of $94.35 million for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +242.6% in Total Assets compared to the prior fiscal year.
- ASP Isotopes Inc. reported Stockholders Equity of $47.90 million for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +193.9% in Stockholders Equity compared to the prior fiscal year.
- ASP Isotopes Inc. reported R&D Expense of $3.14 million for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +310.5% in R&D Expense compared to the prior fiscal year.
- ASP Isotopes Inc. reported Operating Income of -$26.35 million for fiscal year 2024.
- ASP Isotopes Inc. showed a decrease of -64.3% in Operating Income compared to the prior fiscal year.
- ASP Isotopes Inc. reported Gross Profit of $1.60 million for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +1051.0% in Gross Profit compared to the prior fiscal year.
- ASP Isotopes Inc. reported Shares Outstanding of 72.07 million shares for fiscal year 2024.
- ASP Isotopes Inc. showed an increase of +47.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: